Therapeutic and clinical applications of nitroxide compounds

Antioxidants and Redox Signaling

Volumn 9, Issue 10, 2007, Pages 1731-1743

  Soule, Benjamin P ^a   Hyodo, Fuminori ^a   Matsumoto, Ken Ichiro ^a   Simone, Nicole L ^a   Cook, John A ^a   Krishna, Murali C ^a   Mitchell, James B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTHIONINE SULFOXIMINE; CASPASE 3; CONTRAST MEDIUM; FREE RADICAL; GLUTATHIONE; HYDROXYLAMINE; MALEIC ACID DIETHYL ESTER; N(G) NITROARGININE METHYL ESTER; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITROXIDE DERIVATIVE; OXIDOPAMINE; SUPEROXIDE DISMUTASE; TEMPOL; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE; ZINOSTATIN;

ALOPECIA; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTHRITIS; ATAXIA TELANGIECTASIA; CANCER PREVENTION; CATARACT; CELL CYCLE ARREST; CHEMOPROPHYLAXIS; CHO CELL; COLITIS; CONTROLLED STUDY; CYTOTOXICITY; DEGENERATIVE DISEASE; DNA DAMAGE; DOSE RESPONSE; ELECTRON SPIN RESONANCE; FIBROSARCOMA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GUINEA PIG; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; ISCHEMIA; LD 50; MOUSE; MULTIPLE ORGAN FAILURE; MUTAGENICITY; NONHUMAN; OXIDATIVE STRESS; PANCREATITIS; PARKINSON DISEASE; PLEURISY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION PROTECTION; RAT; REPERFUSION INJURY; REVIEW; RHESUS MONKEY; SALIVATION; SPONTANEOUSLY HYPERTENSIVE RAT; UVEORETINITIS; WEIGHT CONTROL;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; HUMANS; HYPERTENSION; MAGNETIC RESONANCE IMAGING; NITROGEN OXIDES; OXIDATION-REDUCTION; RADIATION-PROTECTIVE AGENTS;

EID: 34648816658     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1722     Document Type: Review

References (101)

1. Ankel EG, Lai CS, Hopwood LE, and Zivkovic Z. Cytotoxicity of commonly used nitroxide radical spin probes. Life Sci 40: 495-498, 1987.
2. Berliner LJ, Fujii H, Wan XM, and Lukiewicz SJ. Feasibility study of imaging a living murine tumor by electron paramagnetic resonance. Magn Reson Med 4: 380-384, 1987.
3. Bonnet AM and Houeto JL. Pathophysiology of Parkinson's disease. Biomed Pharmacother 53: 117-121, 1999.
4. Brasch RC. Work in progress: methods of contrast enhancement for NMR imaging and potential applications: a subject review. Radiology 147: 781-788, 1983.
5. Brasch RC, London DA, Wesbey GE, Tozer TN, Nitecki DE, Williams RD, Doemeny J, Tuck LD, and Lallemand DP. Work in progress: nuclear magnetic resonance study of a paramagnetic nitroxide contrast agent for enhancement of renal structures in experimental animals. Radiology 147: 773-779, 1983.
6. Brasch RC, Nitecki DE, Brant-Zawadzki M, Enzmann DR, Wesbey GE, Tozer TN, Tuck LD, Cann CE, Fike JR, and Sheldon P. Brain nuclear magnetic resonance imaging enhanced by a paramagnetic nitroxide contrast agent: preliminary report. AJR Am J Roentgenol 141: 1019-1023, 1983.
7. Brizel DM and Overgaard J. Does amifostine have a role in chemoradiation treatment? Lancet Oncol 4: 378-381, 2003.
8. Brizel DM, Wasserman TH, Henke M, Strnad V, Rudat V, Monnier A, Eschwege F, Zhang J, Russell L, Oster W, and Sauer R. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18: 3339-3345, 2000.
9. Chatterjee PK, Cuzzocrea S, Brown PA, Zacharowski K, Stewart KN, Mota-Filipe H, and Thiemermann C. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int 58: 658-673, 2000.
10. Chen K, Glockner JF, Morse PD 2nd, and Swartz HM. Effects of oxygen on the metabolism of nitroxide spin labels in cells. Biochemistry 28: 2496-2501, 1989.
11. Cheng WH, Zheng X, Quimby FR, Roneker CA, and Lei XG. Low levels of glutathione peroxidase 1 activity in selenium-deficient mouse liver affect c-Jun N-terminal kinase activation and p53 phosphorylation on Ser-15 in pro-oxidant-induced aponecrosis. Biochem J 370: 927-934, 2003.
12. Cotrim AP, Sowers AL, Lodde BM, Vitolo JM, Kingman A, Russo A, Mitchell JB, and Baum BJ. Kinetics of tempol for prevention of xerostomia following head and neck irradiation in a mouse model. Clin Cancer Res 11: 7564-7568, 2005.
13. Cuscela D, Coffin D, Lupton GP, Cook JA, Krishna MC, Bonner RF, and Mitchell JB. Protection from radiation-induced alopecia with topical application of nitroxides: fractionated studies. Cancer J Sci Am 2: 273, 1996.
14. Cuzzocrea S, McDonald MC, Filipe HM, Costantino G, Mazzon E, Santagati S, Caputi AP, and Thiemermann C. Effects of tempol, a membrane-permeable radical scavenger, in a rodent model of carrageenan-induced pleurisy. Eur J Pharmacol 390: 209-222, 2000.
15. Cuzzocrea S, McDonald MC, Mazzon E, Dugo L, Lepore V, Fonti MT, Ciccolo A, Terranova ML, Caputi AP, and Thiemermann C. Tempol, a membrane-permeable radical scavenger, reduces dinitrobenzene sulfonic acid-induced colitis. Eur J Pharmacol 406: 127-137, 2000.
16. Cuzzocrea S, McDonald MC, Mazzon E, Siriwardena D, Costantino G, Fulia F, Cucinotta G, Gitto E, Cordaro S, Barberi I, De Sarro A, Caputi AP, and Thiemermann C. Effects of tempol, a membrane-permeable radical scavenger, in a gerbil model of brain injury. Brain Res 875: 96-106, 2000.
17. Cuzzocrea S, McDonald MC, Mota-Filipe H, Mazzon E, Costantino G, Britti D, Mazzullo G, Caputi AP, and Thiemermann C. Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of collagen-induced arthritis. Arthritis Rheum 43: 320-328, 2000.
18. DeGraff W, Hahn SM, Mitchell JB, and Krishna MC. Free radical modes of cytotoxicity of Adriamycin and streptonigrin. Biochem Pharmacol 48: 1427-1435, 1994.
19. DeGraff WG, Krishna MC, Kaufman D, and Mitchell JB. Nitroxide-mediated protection against X-ray- and neocarzinostatin-induced DNA damage. Free Radic Biol Med 13: 479-487, 1992.
20. DeGraff WG, Krishna MC, Russo A, and Mitchell JB. Antimutagenicity of a low molecular weight superoxide dismutase mimic against oxidative mutagens. Environ Mol Mutagen 19: 21-26, 1992.
21. DeGraff WG and Mitchell JB. Glutathione dependence of neocarzinostatin cytotoxicity and mutagenicity in Chinese hamster V-79 cells. Cancer Res 45: 4760-4762, 1985.
22. Dikalov SI, Vitek MP, Maples KR, and Mason RP. Amyloid beta peptides do not form peptide-derived free radicals spontaneously, but can enhance metal-catalyzed oxidation of hydroxylamines to nitroxides. J Biol Chem 274: 9392-9399, 1999.
23. Dunn JF, O'Hara JA, Zaim-Wadghiri Y, Lei H, Meyerand ME, Grinberg OY, Hou H, Hoopes PJ, Demidenko E, and Swartz HM. Changes in oxygenation of intracranial tumors with carbogen: a BOLD MRI and EPR oximetry study. J Magn Reson Imaging 16: 511-521, 2002.
24. Erker L, Schubert R, Yakushiji H, Barlow C, Larson D, Mitchell JB, and Wynshaw-Boris A. Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor. Hum Mol Genet 14: 1699-1708, 2005.
25. Gariboldi MB, Lucchi S, Caserini C, Supino R, Oliva C, and Monti E. Antiproliferative effect of the piperidine nitroxide TEMPOL on neoplastic and nonneoplastic mammalian cell lines. Free Radic Biol Med 24: 913-923, 1998.
26. Gariboldi MB, Ravizza R, Petterino C, Castagnaro M, Finocchiaro G, and Monti E. Study of in vitro and in vivo effects of the piperidine nitroxide Tempol: a potential new therapeutic agent for gliomas. Eur J Cancer 39: 829-837, 2003.
27. Gariboldi MB, Rimoldi V, Supino R, Favini E, and Monti E. The nitroxide tempol induces oxidative stress, p21 (WAF1/CIP1), and cell death in HL60 cells. Free Radic Biol Med 29: 633-641, 2000.
28. Goffman T, Cuscela D, Glass J, Hahn S, Krishna CM, Lupton G, and Mitchell JB. Topical application of nitroxide protects radiation-induced alopecia in guinea pigs. Int J Radiat Oncol Biol Phys 22: 803-806, 1992.
29. Hahn SM, DeLuca AM, Coffin D, Krishna CM, and Mitchell JB. In vivo radioprotection and effects on blood pressure of the stable free radical nitroxides. Int J Radiat Oncol Biol Phys 42: 839-842, 1998.
30. Hahn SM, Krishna MC, DeLuca AM, Coffin D, and Mitchell JB. Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotector. Free Radic Biol Med 28: 953-958, 2000.
31. Hahn SM, Sullivan FJ, DeLuca AM, Bacher JD, Liebmann J, Krishna MC, Coffin D, and Mitchell JB. Hemodynamic effect of the nitroxide superoxide dismutase mimics. Free Radic Biol Med 27: 529-535, 1999.
32. Hahn SM, Sullivan FJ, DeLuca AM, Krishna CM, Wersto N, Venzon D, Russo A, and Mitchell JB. Evaluation of tempol radioprotection in a murine tumor model. Free Radic Biol Med 22: 1211-1216, 1997.
33. Hahn SM, Tochner Z, Krishna CM, Glass J, Wilson L, Samuni A, Sprague M, Venzon D, Glatstein E, Mitchell JB, and Russo A. Tempol, a stable free radical, is a novel murine radiation protector. Cancer Res 52: 1750-1753, 1992.
34. Hahn SM, Wilson L, Krishna CM, Liebmann J, DeGraff W, Gamson J, Samuni A, Venzon D, and Mitchell JB. Identification of nitroxide radioprotectors. Radiat Res 132: 87-93, 1992.
35. Halpern HJ, Spencer DP, and van Polen J. Imaging radio frequency electron-spin-resonance spectrometer with high resolution and sensitivity for in vivo measurements. Rev Sci Instrum 60: 1040-1050, 1989.
36. Hyodo F, Matsumoto K, Matsumoto A, Mitchell J, and Krishna CM. Probing the intracellular redox status of tumors with magnetic resonance imaging and redox-sensitive contrast agents. Cancer Res 66: 9921-9928, 2006.
37. Ilangovan G, Manivannan A, Li H, Yanagi H, Zweier JL, and Kuppusamy PA. Naphthalocyanine-based EPR probe for localized measurements of tissue oxygenation. Free Radic Biol Med 32: 139-147, 2002.
38. Ito K, Nakazato T, Yamato K, Miyakawa Y, Yamada T, Hozumi N, Segawa K, Ikeda Y, and Kizaki M. Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species. Cancer Res 64: 1071-1078, 2004.
39. Johnstone PA, DeGraff WG, and Mitchell JB. Protection from radiation-induced chromosomal aberrations by the nitroxide Tempol. Cancer 75: 2323-2327, 1995.
40. Keana JF and Pou S. Nitroxide-doped liposomes containing entrapped oxidant: an approach to the "reduction problem" of nitroxides as MRI contrast agents. Physiol Chem Phys Med NMR 17: 235-240, 1985.
41. Keana JF, Pou S, and Rosen GM. Nitroxides as potential contrast enhancing agents for MRI application: influence of structure on the rate of reduction by rat hepatocytes, whole liver homogenate, subcellular fractions, and ascorbate. Magn Reson Med 5: 525-536, 1987.
42. Klingler W, Kreja L, Nothdurft W, and Selig C. Influence of different radioprotective compounds on radiotolerance and cell cycle distribution of human progenitor cells of granulocytopoiesis in vitro. Br J Haematol 119: 244-254, 2002.
43. 2-. or as SOD mimics? J Biol Chem 271: 26026-26031, 1996.
44. Krishna MC and Samuni A. The effect of oxygen at physiological levels on the detection of free radical intermediates by electron paramagnetic resonance. Free Radic Res Commun 18: 239-247, 1993.
45. Krishna MC, Samuni A, Taira J, Goldstein S, Mitchell JB, and Russo A. Stimulation by nitroxides of catalase-like activity of hemeproteins: kinetics and mechanism. J Biol Chem 271: 26018-26025, 1996.
46. Kuppusamy P, Afeworki M, Shankar RA, Coffin D, Krishna MC, Hahn SM, Mitchell JB, and Zweier JL. In vivo electron paramagnetic resonance imaging of tumor heterogeneity and oxygenation in a murine model. Cancer Res 58: 1562-1568, 1998.
47. Kuppusamy P, Chzhan M, Vij K, Shteynbuk M, Lefer DJ, Giannella E, and Zweier JL. Three-dimensional spectral-spatial EPR imaging of free radicals in the heart: a technique for imaging tissue metabolism and oxygenation. Proc Natl Acad Sci U S A 91: 3388-3392, 1994.
48. Kuppusamy P, Li H, Ilangovan G, Cardounel AJ, Zweier JL, Yamada K, Krishna MC, and Mitchell JB. Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. Cancer Res 62: 307-312, 2002.
49. Leach M, Frank S, Olbrich A, Pfeilschifter J, and Thiemermann C. Decline in the expression of copper/zinc superoxide dismutase in the kidney of rats with endotoxic shock: effects of the superoxide anion radical scavenger, tempol, on organ injury. Br J Pharmacol 125: 817-825, 1998.
50. Leunbach I. On a novel MRI technique (OMRI) for the determination of tissue parameters. Acta Anaesthesiol Scand Suppl 110: 121-122, 1997.
51. Liang Q, Smith AD, Pan S, Tyurin VA, Kagan VE, Hastings TG, and Schor NF. Neuroprotective effects of TEMPOL in central and peripheral nervous system models of Parkinson's disease. Biochem Pharmacol 70: 1371-1381, 2005.
52. Liebmann J, DeLuca AM, Epstein A, Steinberg SM, Morstyn G, and Mitchell JB. Protection from lethal irradiation by the combination of stem cell factor and tempol. Radiat Res 137: 400-404, 1994.
53. Liu KJ, Gast P, Moussavi M, Norby SW, Vahidi N, Walczak T, Wu M, and Swartz HM. Lithium phthalocyanine: a probe for electron paramagnetic resonance oximetry in viable biological systems. Proc Natl Acad Sci U S A 90: 5438-5442, 1993.
54. Martinez M, Martinez N, Hernandez AI, and Ferrandiz ML. Hypothesis: can N-acetylcysteine be beneficial in Parkinson's disease? Life Sci 64: 1253-1257, 1999.
55. Matsumoto K, Fuminori H, Matsumoto A, Koretsky AP, Sowers AL, Mitchell J, and Krishna CM. High-resolution mapping of tumor redox status by magnetic resonance imaging using nitroxides as redox-sensitive contrast agents. Clin Cancer Res 12: 2455-2462, 2006.
56. McCay CM, Crowell CB, and Maynard LA. The effect of retarded growth upon the length of life span and upon the ultimate body size. J Nutr 10: 63-79, 1935.
57. McDonald MC, Zacharowski, K, Bowes J, Cuzzocrea S, and Thiemermann C. Tempol reduces infarct size in rodent models of regional myocardial ischemia and reperfusion. Free Radic Biol Med 27: 493-503, 1999.
58. Merad-Boudia M, Nicole A, Santiard-Baron D, Saille C, and Ceballos-Picot I. Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease. Biochem Pharmacol 56: 645-655, 1998.
59. Metz JM, Smith D, Mick R, Lustig R, Mitchell J, Cherakuri M, Glatstein E, and Hahn SM. A phase I study of topical Tempol for the prevention of alopecia induced by whole brain radiotherapy. Clin Cancer Res 10: 6411-6417, 2004.
60. Mitchell JB, DeGraff W, Kaufman D, Krishna MC, Samuni A, Finkelstein E, Ahn MS, Hahn SM, Gamson J, and Russo A. Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempol. Arch Biochem Biophys 289: 62-70, 1991.
61. Mitchell JB, Russo A, Kuppusamy P, and Krishna MC. Radiation, radicals, and images. Ann N Y Acad Sci 899: 28-43, 2000.
62. Mitchell JB, Samuni A, Krishna MC, DeGraff WG, Ahn MS, Samuni U, and Russo A. Biologically active metal-independent superoxide dismutase mimics. Biochemistry 29: 2802-2807, 1990.
63. Mitchell JB, Xavier S, DeLuca AM, Sowers AL, Cook JA, Krishna MC, Hahn SM, and Russo A. A low molecular weight antioxidant decreases weight and lowers tumor incidence. Free Radic Biol Med 34: 93-102, 2003.
64. Monti E, Supino R, Colleoni M, Costa B, Ravizza R, and Gariboldi MB. Nitroxide Tempol impairs mitochondrial function and induces apoptosis in HL60 cells. J Cell Biochem 82: 271-276, 2001.
65. Mota-Filipe H, McDonald MC, Cuzzocrea S, and Thiemermann C. A membrane-permeable radical scavenger reduces the organ injury in hemorrhagic shock. Shock 12: 255-261, 1999.
66. Osborne TB, Mendel LB, and Ferry EL. The effect of retardation of growth upon the breeding period and duration of life of rats. Science 45: 294-295, 1917.
67. Patel K, Chen Y, Dennehy K, Blau J, Connors S, Mendonca M, Tarpey M, Krishna M, Mitchell JB, Welch WJ, and Wilcox CS. Acute antihypertensive action of nitroxides in the spontaneously hypertensive rat. Am J Physiol Regul Integr Comp Physiol 290: R37-R43, 2006.
68. Rak R, Chao DL, Pluta RM, Mitchell JB, Oldfield EH, and Watson JC. Neuroprotection by the stable nitroxide Tempol during reperfusion in a rat model of transient focal ischemia. J Neurosurg 92: 646-651, 2000.
69. Reddan JR, Giblin FJ, Kadry R, Leverenz VR, Pena JT, and Dziedzic DC. Protection from oxidative insult in glutathione depleted lens epithelial cells. Exp Eye Res 68: 117-127, 1999.
70. Reddan JR, Sevilla MD, Giblin FJ, Padgaonkar V, Dziedzic DC, Leverenz V, Misra IC, and Peters JL. The superoxide dismutase mimic TEMPOL protects cultured rabbit lens epithelial cells from hydrogen peroxide insult. Exp Eye Res 56: 543-554, 1993.
71. Samuni A, Krishna CM, Mitchell JB, Collins CR, and Russo A. Superoxide reaction with nitroxides. Free Radic Res Commun 9: 241-249, 1990.
72. Samuni A, Krishna CM, Riesz P, Finkelstein E, and Russo A. A novel metal-free low molecular weight superoxide dismutase mimic. J Biol Chem 263: 17921-17924, 1988.
73. Samuni A, Mitchell JB, DeGraff W, Krishna CM, Samuni U, and Russo A. Nitroxide SOD-mimics: modes of action. Free Radic Res Commun 12-13: 187-194, 1991.
74. Samuni A, Winkelsberg D, Pinson A, Hahn SM, Mitchell JB, and Russo A. Nitroxide stable radicals protect beating cardiomyocytes against oxidative damage. J Clin Invest 87: 1526-1530, 1991.
75. Samuni AM and Barenholz Y. Stable nitroxide radicals protect lipid acyl chains from radiation damage. Free Radic Biol Med 22: 1165-1174, 1997.
76. Samuni AM, DeGraff W, Cook JA, Krishna MC, Russo A, and Mitchell JB, The effects of antioxidants on radiation-induced apoptosis pathways in TK6 cells. Free Radic Biol Med 37: 1648-1655, 2004.
77. Schnackenberg CG, Welch WJ, and Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 32: 59-64, 1998.
78. Schnackenberg CG and Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin F2alpha. Hypertension 33: 424-428, 1999.
79. Schubert R, Erker L, Barlow C, Yakushiji H, Larson D, Russo A, Mitchell JB, and Wynshaw-Boris A. Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice. Hum Mol Genet 13: 1793-1802, 2004.
80. Sentjurc M, Pecar S, Chen K, Wu M, and Swartz H. Cellular metabolism of proxyl nitroxides and hydroxylamines. Biochim Biophys Acta 1073: 329-335; 1991.
81. Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, and Koretsky AP. MRI detection of single particles for cellular imaging. Proc Natl Acad Sci U S A 101: 10901-10906, 2004.
82. Sies H. Oxidative stress: oxidants and antioxidants. London: Academic Press, 1991.
83. Sledzinski Z, Wozniak M, Antosiewicz J, Lezoche E, Familiari M, Bertoli E, Greci L, Brunelli A, Mazera N, and Wajda Z. Protective effect of 4-hydroxy-TEMPO, a low molecular weight superoxide dismutase mimic, on free radical toxicity in experimental pancreatitis. Int J Pancreatol 18: 153-160, 1995.
84. Spector A and Garner WH. Hydrogen peroxide and human cataract. Exp Eye Res 33: 673-681, 1981.
85. Spencer JP, Jenner P, Daniel SE, Lees AJ, Marsden DC, and Halliwell B. Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species. J Neurochem 71: 2112-2122, 1998.
86. Stewart FA, Rojas A, and Denekamp J. Radioprotection of two mouse tumors by WR-2721 in single and fractionated treatments. Int J Radiat Oncol Biol Phys 9: 507-513, 1983.
87. Swartz HM. Principles of the metabolism of nitroxides and their implications for spin trapping. Free Radic Res Commun 9: 399-405, 1990.
88. Swartz HM, Chen K, Pals M, Sentjurc M, and Morse PD 2nd. Hypoxia-sensitive NMR contrast agents. Magn Reson Med 3: 169-174, 1986.
89. Swartz HM, Sentjurc M, and Morse PD 2nd. Cellular metabolism of water-soluble nitroxides: effect on rate of reduction of cell/nitroxide ratio, oxygen concentrations and permeability of nitroxides. Biochim Biophys Acta 888: 82-90, 1986.
90. Vitolo JM, Cotrim AP, Sowers AL, Russo A, Wellner RB, Pillemer SR, Mitchell JB, and Baum BJ. The stable nitroxide tempol facilitates salivary gland protection during head and neck irradiation in a mouse model. Clin Cancer Res 10: 1807-1812, 2004.
91. von Sonntag C. The chemical basis of radiation biology. London: Taylor and Francis, 1987.
92. Weindruch R. Caloric restriction and aging. Sci Am 274: 46-52, 1996.
93. Xavier S, Yamada K, Samuni AM, Samuni A, DeGraff W, Krishna MC, and Mitchell JB. Differential protection by nitroxides and hydroxylamines to radiation-induced and metal ion-catalyzed oxidative damage. Biochim Biophys Acta 1573: 109-120, 2002.
94. Yamada KI, Kuppusamy P, English S, Yoo J, Irie A, Subramanian S, Mitchell JB, and Krishna MC. Feasibility and assessment of non-invasive in vivo redox status using electron paramagnetic resonance imaging. Acta Radiol 43: 433-440, 2002.
95. Yuhas JM. Efficacy testing of WR-2721 in Great Britain: everything is black and white at the gray lab. Int J Radiat Oncol Biol Phys 9: 595-598, 1983.
96. Yuhas JM, Spellman JM, and Culo F. The role of WR-2721 in radiotherapy and/or chemotherapy. Cancer Clin Trials 3: 211-216, 1980.
97. Yuhas JM and Storer JB. Differential chemoprotection of normal and malignant tissues. J Natl Cancer Inst 42: 331-335, 1969.
98. Zamir E, Zhang R, Samuni A, Kogan M, and Pe'er J. Nitroxide stable radical suppresses autoimmune uveitis in rats. Free Radic Biol Med 27: 7-15, 1999.
99. Zhang J, Perry G, Smith MA, Robertson D, Olson SJ, Graham DG, and Montine TJ. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am J Pathol 154: 1423-1429, 1999.
100. Zigler JS Jr, Qin C, Kamiya T, Krishna MC, Cheng Q, Tumminia S, and Russell P. Tempol-H inhibits opacification of lenses in organ culture. Free Radic Biol Med 35: 1194-1202, 2003.
101. Zollner S, Haseloff RF, Kirilyuk IA, Blasig IE, and Rubanyi GM. Nitroxides increase the detectable amount of nitric oxide released from endothelial cells. J Biol Chem 272: 23076-23080, 1997.